Comparing the Stanford Letter Project Form to Traditional Advance Directives
NCT ID: NCT02799537
Last Updated: 2024-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1000 participants
INTERVENTIONAL
2016-02-29
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of an Easy to Read Advance Directive Versus a Standard Advance Directive
NCT00328055
Impact of Active Choice on Advance Directive Completion Rates
NCT02289105
Patient Perception of Video Advance Care Planning
NCT02692950
Default Options in Advance Directives
NCT02017548
A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease
NCT03557086
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Step 2:
Online Stanford consent form will be presented before the participants. Only after they read the consent and click on the participation link will they be able to enter the study.Those who are willing to participate will be randomly assigned to either the letter or traditional advance directives in Spanish and study measures. They will also answer questions as to how much they liked and understood the documents.
Step 4: The investigators will collect data until the investigators reach an n=1000
Step 5: The investigators will analyze the results and submit for publication.
In this protocol, we are assessing whether patients prefer the traditional advance directives or the letter directive. As it is just an questionnaire based study, there no risk for patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Participants in the intervention arm complete the Stanford letter advance directive
Randomized clinical study
Participants will be randomly assigned to one of two advance directives and we will assess which they prefer. This is not a human health intervention
Control
Participants in the control arm complete the California state traditional advance directive
Randomized clinical study
Participants will be randomly assigned to one of two advance directives and we will assess which they prefer. This is not a human health intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Randomized clinical study
Participants will be randomly assigned to one of two advance directives and we will assess which they prefer. This is not a human health intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
VJ Periyakoil
Clinical Associate Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
VJ Periyakoil, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
VJ Periyakoil, MD
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
This site contains the English and Spanish versions of the letter directive.
This site contains the English and Spanish versions of the traditional advance directive.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
36786
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.